Heat shock protein gp96-peptide complex (gp96-peptide complex)

Heat shock protein gp96-peptide complexes are formed when the molecular chaperone glycoprotein 96 (gp96), also known as glucose-regulated protein 94 or grp94, binds short peptides—often derived from tumor antigens or viral proteins—within the endoplasmic reticulum. Gp96 is a member of the HSP90 family and functions primarily as a molecular chaperone involved in proper folding and assembly of client proteins. When isolated from tumors or infected cells along with their associated peptides, these complexes can be used to stimulate potent antigen-specific immune responses. The immunogenicity arises because dendritic cells efficiently take up these complexes via receptor-mediated endocytosis. The bound peptides are then cross-presented on MHC class I molecules to CD8+ cytotoxic T lymphocytes. This mechanism underlies experimental cancer vaccines that use autologous tumor-derived gp96–peptide complexes to induce anti-tumor immunity without genetic modification or viral vectors. Gp96-based peptide complexes have shown promise in preclinical models against various cancers—including melanoma, colon cancer, lung cancer—and have advanced into clinical trials for melanoma and renal cell carcinoma patients. Their ability to activate CTLs specifically against tumor antigens makes them attractive candidates for personalized immunotherapy approaches.[1][2][4]

Other names

Glycoprotein 96-peptide complexGlucose-regulated protein 94 (grp94)-peptide complexHSP90B1-peptide complexEndoplasmin-peptide complex

Acts as an adjuvant by delivering tumor or viral peptides to antigen-presenting cells for cross-presentation on MHC class I molecules, thereby stimulating CD8+ T cell responses and antitumor/antiviral immunity[2].